loading

Revolution Medicines Inc Azioni (RVMD) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
13.46%
505.13
445.22 361.63 315.27 264.71
Operating Income/Loss
13.46%
-505.13
-445.22 -361.63 -315.27 -264.71
Nonoperating Income/Loss
1,520%
-139.24
-8.594 -3.266 10.06 16.93
Income/Loss From Continuing Operations Before Tax
41.99%
-644.37
-453.82 -364.89 -305.21 -247.79
Net Income/Loss
41.99%
-644.37
-453.82 -364.89 -305.21 -247.79
Basic Average Shares
6.46%
210.89
198.10 1.4716 189.23 188.58
Diluted Average Shares
6.46%
210.89
198.10 1.4716 189.23 188.58
Basic Earnings Per Share
33.62%
-3.06
-2.29 -1.89 -1.61 -1.31
Diluted Earnings Per Share
33.62%
-3.06
-2.29 -1.89 -1.61 -1.31
ONC ONC
$350.08
price down icon 0.09%
$801.24
price down icon 1.36%
$223.28
price down icon 1.65%
$56.53
price down icon 2.16%
$34.00
price down icon 1.71%
$36.87
price down icon 1.35%
Capitalizzazione:     |  Volume (24 ore):